arrow
C

Camilla Qvortrup

copenhagen university hospital
H指数:27
被引数:4,907

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment of localized rectal cancer in the Nordic countries—comparison of Nordic to Dutch, ESMO, and NCCN guidelines

北欧国家局部直肠癌的治疗——北欧指南与荷兰、ESMO及NCCN指南的比较

2026-07-200
PRE
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer - A post-hoc exploratory analysis of the randomized NORDIC9-studye

BRAFV600E突变对易受伤害的老年转移性结直肠癌患者的生存和治疗效果的影响-随机NORDIC9-studye的事后探索性分析

2024-03-010
OA
Therapy with pembrolizumab in treatment-naive patients with nonmetastatic, mismatch repair deficient colorectal cancer

pembrolizumab治疗未接受治疗的非转移性、错配修复缺陷型结直肠癌患者

2023-01-187
OA
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study

在BRAF V600E突变的转移性结直肠癌患者中,每日一次的恩可非尼联合两周一次的西妥昔单抗的II期研究: 新的BEACON研究

2022-12-165
OAAI
The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study
2022-09-239
OAAI
The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study
2022-09-010
OAAI